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M O L E C U L A R  B I O L O G Y
Mus81-Eme1–dependent aberrant processing of DNA 
replication intermediates in mitosis impairs 
genome integrity
Nicolás Luis Calzetta*, Marina Alejandra González Besteiro*†, Vanesa Gottifredi†
Chromosome instability (CIN) underpins cancer evolution and is associated with drug resistance and poor prognosis. 
Understanding the mechanistic basis of CIN is thus a priority. The structure-specific endonuclease Mus81-Eme1 is 
known to prevent CIN. Intriguingly, however, here we show that the aberrant processing of late replication inter-
mediates by Mus81-Eme1 is a source of CIN. Upon depletion of checkpoint kinase 1 (Chk1), Mus81-Eme1 cleaves 
under-replicated DNA engaged in mitotic DNA synthesis, leading to chromosome segregation defects. Supple-
menting cells with nucleosides allows the completion of mitotic DNA synthesis, restraining Mus81-Eme1–dependent 
DNA damage in mitosis and the ensuing CIN. We found no correlation between CIN arising from nucleotide shortage 
in mitosis and cell death, which were selectively linked to DNA damage load in mitosis and S phase, respectively. 
Our findings imply the possibility of optimizing Chk1-directed therapies by inducing cell death while curtailing CIN, 
a common side effect of chemotherapy.
INTRODUCTION
The DNA damage response (DDR), a complex network of inter-
dependent signaling pathways activated upon DNA insults, assists 
the completion and fidelity of DNA replication. DDR defects are 
common across multiple cancers. Conventional anticancer therapy 
exploits this vulnerability by the use of chemicals or radiation that 
inflicts direct damage to the DNA. Along the same principle, DDR 
inhibitors have been introduced in clinical practice and have recently 
revolutionized the therapeutic landscape of cancer (1). One drawback 
of this strategy is that high levels of DNA damage and/or an inefficient 
DDR induce chromosome instability (CIN). CIN collectively refers to 
changes in chromosome number and structure, which can result from 
chromosome mis-segregation (2). The genetic diversity created by CIN 
provides tumor cells with growth advantages. Thus, contemporary 
anticancer therapy is a potential driver of malignancy. CIN is associated 
with poor prognosis and cancer relapse and correlates with resistance 
to antineoplastic treatments, both in tumor- derived cell lines and in 
clinical settings (2, 3). Optimizing therapies to suppress tumor growth 
while minimizing CIN is essential to addressing this clinical issue.
Checkpoint kinase 1 (Chk1) is a key mediator of the DDR that 
delays S phase progression, stabilizes replication forks, and promotes 
DNA repair upon replication stress (4). Chk1 inhibitors (Chk1i) are 
undergoing clinical evaluation in monotherapy or combination 
regimens (1). The current model prescribes that Chk1i unleash origin 
firing, slow down forks, and cause double-strand breaks (DSBs), 
perturbing the replication choreography and culminating in genomic 
instability and cell death (4–6). The link between altered replication 
dynamics, DSBs, and cell death has been unequivocally proven in 
Chk1-deficient cells (7–11). In particular, robust evidence has shown 
that Mus81-Eme2–dependent cleavage of stalled forks in S phase 
compromises cell survival upon Chk1 loss (8). Although surpassing 
a certain threshold of genomic instability is incompatible with cell 
survival (12), no unambiguous relationship has been established be-
tween genomic instability and cell death in Chk1-deficient cells (6).
The literature provides only scarce and isolated information on 
the contribution of Chk1 to genomic stability. A few reports have 
shown that Chk1 deficiency in cancer cells leads to the accumula-
tion of CIN markers such as anaphase bridges, lagging chromosomes, 
and ultrafine bridges (UFBs) (13–15). These phenotypes are often 
the manifestation of under-replicated DNA (UR-DNA) being passed 
onto mitosis (16–19). DNA under-replication leads to nascent DNA 
synthesis in early mitosis, i.e., mitotic DNA synthesis (MiDAS). The 
inactivation of various DDR effectors induces UR-DNA and MiDAS 
(20–24). However, it remains unknown whether Chk1 loss induces 
UR-DNA and MiDAS and whether mitotic events prevent or pro-
mote CIN in Chk1-deficient cells.
MiDAS operates at common fragile sites and telomeres upon 
treatment with the DNA polymerase inhibitor aphidicolin (APH) 
(25). APH-induced MiDAS takes place in prophase to complete DNA 
duplication and thereby promote the proper segregation of sister 
chromatids in anaphase (22, 24, 26, 27). However, MiDAS is not 
necessarily restricted to origin-poor, late-replicating regions (28). 
Besides, MiDAS might not always fully complete DNA replication; 
instead, MiDAS might constitute the first step in the resolution of 
UR-DNA, which would ultimately take place during the next S phase 
within structures shielded by 53BP1 (16, 29). Our knowledge on the 
mechanistic details underlying MiDAS is similarly scarce and entirely 
restricted to studies with APH. APH-induced MiDAS is apparently 
not about the continuation of conventional, semiconservative repli-
cation that takes place in S phase (25). Instead, APH-induced 
MiDAS might represent a form of break-induced replication (BIR), 
a recombination-based pathway that repairs one-ended breaks in 
yeasts (24–26). During APH-induced MiDAS, the break that precedes 
replication is formed by a structure-specific endonuclease, Mus81-
Eme1, or other nuclease functioning in complex with the SLX4 scaffold 
(22, 26). Together, much work still needs to be done to unveil the 
molecular details underlying MiDAS, its contribution to chromosome 
segregation, and its implications for cancer therapy.
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Here, we demonstrate that Chk1 knockdown triggers the accu-
mulation of UR-DNA, MiDAS intermediates, and aberrant anaphases. 
In contrast to APH-induced MiDAS, MiDAS in Chk1-depleted cells 
is not initiated by Mus81-Eme1–dependent cleavage of UR-DNA. 
Instead, Mus81-Eme1 functions downstream of MiDAS initiation 
in Chk1-depleted cells—it cleaves nascent DNA synthetized during 
mitosis. Such function of Mus81-Eme1 is activated because the 
nucleotide pool is insufficient to sustain MiDAS. This unprecedented 
role of Mus81-Eme1 propels CIN but does not compromise cell 
survival. Instead, cell death upon Chk1 inactivation is entirely de-
pendent on Mus81-Eme2–mediated DSBs in S phase. Our data imply 
that treating cancer with Chk1i could unnecessarily lead to an en-
richment of a chromosomally unstable subpopulation. We believe 
that our findings should be taken into consideration when design-
ing Chk1-directed therapies.
RESULTS
Chk1 loss triggers replication catastrophe and chromosome 
mis-segregation by independent pathways
We have recently identified excess chromatin binding of the helicase 
cofactor CDC45 as the cause of increased origin firing and asym-
metric fork slowdown in Chk1-deficient cells (9). Partial depletion 
of CDC45 does not interfere with cell proliferation (9, 30, 31), but it 
does nullify the massive accumulation of DNA damage and DSBs in 
Chk1-depleted U2OS cells (Fig. 1, A to C). These results are in good 
agreement with reports that have also partially inactivated CDC45 in 
Chk1-inhibited or Chk1-depleted cells (30–32). Hence, surplus CDC45 
in Chk1-defective cells results in replication catastrophe, manifested 
as pan-nuclear H2AX and a large number of DSBs per cell.
Replication stress often results in chromosome mis-segregation 
(6, 16, 23, 33). We then asked whether excess origin firing and fork 
slowdown result in chromosome mis-segregation in Chk1-deficient 
cells [phenotypes in S and M phases were determined 48 and 72 hours 
after transfection with small interfering RNA (siRNA), respectively; 
fig. S1A]. To this end, we measured the percentage of cells with 
anaphase aberrations and micronuclei after concomitant down- 
regulation of Chk1 and CDC45. Chk1-defective U2OS cells showed 
a steep increase in anaphase aberrations and micronuclei (Fig. 1, 
D and E, and fig. S1, B and C). However, CDC45 down-regulation 
failed to revert the chromosome segregation errors provoked by 
Chk1 loss (Fig. 1, D and E). This independency between altered rep-
lication dynamics and micronuclei accumulation was also observed 
in HCT116 and PANC-1 cells (fig. S2, A and B), whose replication 
speed was also fine-tuned by CDC45 expression levels (fig. S2, C 
and D). Thus, upon Chk1 loss, the replication catastrophe that fol-
lows origin usage and fork elongation defects is dissociated from 
chromosome mis-segregation (Fig. 1F).
Mus81 triggers CIN in Chk1-deficient cells
We next sought to identify the molecular triggers of chromosome 
mis-segregation in Chk1-depleted cells. Upon Chk1 loss, the un-
scheduled activation of the structure-specific endonuclease Mus81 
leads to the accumulation of pan-nuclear H2AX and DSBs in 
S phase (fig. S3, A to C) (7, 8, 10). Because chromosome segregation 
errors arise independently of the replication catastrophe elicited 
by Chk1 loss (Fig. 1, A to F), we predicted that Mus81 would not 
contribute to chromosome mis-segregation. Unexpectedly, how-
ever, increased rates of anaphase aberrations and micronuclei in 
Chk1-deficient cells did depend on Mus81 (fig. S3, D and E). In 
HCT116 and PANC-1 cells, Mus81 down-regulation also prevented 
the occurrence of micronuclei provoked by Chk1 inactivation 
(fig. S4, A and B). While these data indicate that Mus81-dependent 
DSBs precede the chromosome segregation errors elicited by 
Chk1 depletion, neutral comet assays did not reveal an associa-
tion between DSB formation and chromosome mis-segregation 
(Fig. 1, A to F). This apparent contradiction might be explained by 
the fact that only cells with more than 50 DSBs generate a tail that 
can be detected by the neutral comet assay (34). Thus, after Chk1 
depletion, chromosome mis-segregation might take place in cells 
that accumulate just a few Mus81-dependent DSBs.
Mus81-Eme1–dependent DSBs in mitosis trigger CIN 
in Chk1-deficient cells
Mus81 is the catalytic subunit of two human structure-selective endo-
nucleases, Mus81-Eme1 and Mus81-Eme2 (35, 36). Unrestrained 
Mus81-Eme2–dependent cleavage of S phase replication intermediates 
leads to pan-nuclear H2AX accumulation in cells deficient in Chk1 
or WEE1, another DDR protein (37, 38). Notwithstanding this, our 
data suggest that Mus81 operates in an additional pathway upon 
Chk1 loss; this pathway is independent of quantifiable fork stalling 
in S phase and leads to chromosome mis-segregation. We hypothe-
sized that the two functions of Mus81 in Chk1-depleted cells require 
either Eme1 or Eme2. Pan-nuclear H2AX accumulation and DSBs, 
as measured by neutral comet assay, depended on Eme2 but not on 
Eme1 (Fig. 2, A to C, and fig. S5, A and B). In sharp contrast, the 
increase in anaphase aberrations and micronuclei depended on Eme1 
but not on Eme2 (Fig. 2, D and E, and fig. S5C).
Mus81-Eme2 and Mus81-Eme1 might function preferentially in 
S and M phases, respectively (39). The fact that Mus81-Eme1 leads 
to chromosome mis-segregation in Chk1-depleted cells points to 
mitotic DSBs as a prelude to such kind of CIN. Mitotic DSBs can be 
visualized directly as gaps/breaks in condensed, Giemsa-stained 
metaphase chromosomes (18, 19) or indirectly as H2AX foci (40). 
In agreement with our hypothesis, Chk1 depletion increased the in-
cidence of chromosomal gaps/breaks (Fig. 3A) and mitotic H2AX 
foci (Fig. 3B). Moreover, the induction of mitotic DSBs depended 
on Mus81 and Eme1 but not on CDC45 or Eme2 (Fig. 3, A to C). So, 
contrary to the Mus81-Eme2–dependent, extensive chromosome 
pulverization observed in WEE1-inhibited cells (38), mitotic DNA 
damage in Chk1-depleted cells depends on Mus81-Eme1 and mani-
fests as discrete DSBs. Together, our results provide strong evidence 
that Mus81-Eme1–dependent DSBs in mitosis conduce to chromosome 
mis-segregation, whereas Mus81-Eme2–dependent DSBs in S phase 
do not (Fig. 3D).
MiDAS precedes Mus81-Eme1–dependent cleavage and CIN 
in Chk1-deficient cells
Mus81-Eme1–dependent DSBs in mitosis are well-known protectors 
of genome integrity (18, 19, 26). Our data indicate that Mus81-Eme1–
dependent DSBs in mitosis are triggers of CIN as well; we then 
sought to understand the molecular basis of such an unprecedented 
role of Mus81-Eme1. Mus81-Eme1 cleaves DNA replication inter-
mediates (35), and DNA synthesis may take place during early mitosis 
(21, 26). We thus hypothesized that late replication intermediates 
constitute the substrates for Mus81-Eme1–dependent cleavage. 
Chk1 depletion increased the percentage of cells that incorporated 
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Fig. 1. Chk1 loss triggers replication catastrophe and chromosome mis-segregation by independent pathways. (A) Western blot of H2AX, phospho-RPA32 Ser4/8, 
phospho-KAP1 Ser824, KAP1, Chk1, and CDC45 in U2OS cells, 48 hours after transfection. The left panel shows the chromatin fraction, obtained after an extraction with CSK 
buffer; the right panel shows whole-cell extracts. H2B and actin were used as loading controls. (B) Percentage (mean ± SD) and representative images of U2OS cells with 
pan-nuclear H2AX staining. More than 2000 cells per sample were analyzed in three independent experiments. Scale bar, 20 m. As in all graphs in the manuscript, dif-
ferent letters indicate significant differences (see Materials and Methods). (C) Quantification by neutral comet assay of DSB accumulation in U2OS cells (A.U., arbitrary 
units). The right panel shows representative images of DNA comets. Three hundred cells per sample were analyzed in three independent experiments. The bars on top of 
the distribution clouds indicate the median. Scale bar, 10 m. (D) Percentage (mean ± SD) and representative Z-stack images of U2OS anaphase cells with aberrations. 
About 150 anaphases per sample were analyzed in three independent experiments. The total percentage of aberrant anaphases (bridges plus lagging chromosomes) was 
used to calculate the statistics. Scale bar, 5 m. (E) Percentage (mean ± SD) and representative images of binucleated U2OS cells with micronuclei. About 750 binucleated 
cells per sample were analyzed in three independent experiments. Scale bar, 10 m. (F) Excess CDC45 in Chk1-deficient cells provokes DSBs and acute replication stress 










Calzetta et al., Sci. Adv. 2020; 6 : eabc8257     9 December 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
4 of 13
Fig. 2. Mus81-Eme1 triggers CIN in Chk1-deficient cells. (A) Quantitative real-time PCR of Eme1 and Eme2 normalized to GAPDH in U2OS cells, 48 hours after transfection; 
error bars represent the SD of two technical replicates. (B) Percentage of U2OS cells with pan-nuclear H2AX staining (mean ± SD). More than 1600 cells per sample were 
analyzed in two independent experiments. (C) Quantification by neutral comet assay of DSB accumulation in U2OS cells. Three hundred cells per sample were analyzed 
in three independent experiments. The bars on top of the distribution clouds indicate the median. (D) Percentage of U2OS anaphase cells with aberrations (mean ± SD). 
About 100 anaphases per sample were analyzed in two independent experiments. The total percentage of aberrant anaphases (bridges plus lagging chromosomes) 
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(Fig. 4A); EdU foci colocalized with FANCD2 (Fig. 4A), a marker of 
DNA synthesis in mitosis (21, 26). siChk1-induced MiDAS took place 
independently of Mus81 (fig. S6A), in sharp contrast with APH- 
induced MiDAS, which requires Mus81 [fig. S6B and (24, 26, 27)]. 
The depletion of the Mus81 scaffold SLX4, which phenocopies the 
depletion of Mus81, had also no effect on siChk1-induced MiDAS 
(fig. S6, C to F). These results reinforce the notion that Mus81-Eme1 
acts downstream of MiDAS in Chk1-deficient cells.
To directly test this hypothesis, we visualized the pattern of EdU 
incorporation on DAPI (4′,6-diamidino-2-phenylindole)–stained 
Fig. 3. Mus81-Eme1 triggers mitotic DSBs in Chk1-deficient cells. (A) Percentage of metaphase chromosomes with breaks/gaps (mean ± SD) and representative images 
of intact or broken chromosomes and whole metaphase spreads. HCT116 cells were transfected with the indicated siRNAs and transduced 5 hours later with nontargeting 
shRNA [shScramble (shScr)] or shRNA targeting Chk1 (shChk1). About 4500 chromosomes (from 100 metaphases) per sample were analyzed in two independent experiments. 
Scale bars, 1 m. (B) Percentage (mean ± SD) and representative Z-stack images of mitotic U2OS cells with >10 H2AX foci. About 150 metaphases per sample were analyzed 
in three independent experiments. Scale bar, 5 m. (C) Percentage of mitotic U2OS cells with >10 H2AX foci (mean ± SD). About 120 metaphases per sample were 
analyzed in three independent experiments. (D) Model in which Mus81-Eme1–dependent DSBs in mitosis trigger CIN in Chk1-deficient cells, independently of Mus81-
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Fig. 4. DNA synthesis in mitosis precedes Mus81-Eme1–dependent cleavage and CIN in Chk1-deficient cells. (A) Percentage (mean ± SD) and representative Z-stack 
images of mitotic U2OS cells with EdU/FANCD2 spots. About 100 metaphases per sample were analyzed in two independent experiments. Scale bar, 5 m. (B) Percentage 
(mean ± SD) and representative images of HCT116 chromosomes (DAPI, red) with semiconservative, conservative, or complex patterns of EdU incorporation (green). APH 
(0.2 M) was added as a control, 24 hours before EdU incorporation. Only shChk1-transduced and APH-treated samples are shown, because shScr-transduced and 
DMSO-treated samples did not exhibit EdU incorporation. Four hundred EdU-positive events per sample were analyzed in two independent experiments. Scale bar, 1 m. 
(C) DAPI-negative breaks (white arrows) at sites of EdU incorporation in metaphase chromosomes from shChk1-transduced HCT116 cells. No breaks were detected in 
EdU-negative DNA. Scale bar, 1 m. (D) Percentage of EdU-positive events with breaks (mean ± SD) in HCT116 metaphase chromosomes. Four hundred EdU-positive 
events per sample were analyzed in two independent experiments. The representative images depict Eme1-dependent chromosome breakage at sites of shChk1-induced 
EdU incorporation. Scale bar, 1 m. (E) Quantitative real-time PCR of PolD3 and Rad52 normalized to GAPDH in U2OS cells, 48 hours after transfection; error bars represent 
the SD of two technical replicates. (F) Percentage of mitotic U2OS cells with EdU spots (mean ± SD). About 120 metaphases per sample were analyzed in three independent 
experiments. (G) Percentage of mitotic U2OS cells with >10 H2AX foci (mean ± SD). About 100 metaphases per sample were analyzed in three independent experiments. 
(H) Percentage of U2OS anaphase cells with aberrations (mean ± SD). About 100 anaphases per sample were analyzed in two independent experiments. Total percentage 
of aberrant anaphases was used to perform the statistics. (I) Percentage of binucleated U2OS cells with micronuclei (mean ± SD). About 400 binucleated cells per sample 
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metaphase spreads, which allows simultaneous detection of DNA 
synthesis in early mitosis and Mus81-dependent DSBs, visible as 
DAPI-negative gaps/breaks (26). EdU incorporation was only detect-
able in Chk1-depleted cells and not in control samples. The vast 
majority of metaphase chromosomes incorporating EdU did so in a 
pattern consistent with semiconservative replication (Fig. 4B, “both 
chromatids”). This might abrogate the need for a break before DNA 
synthesis; these results are thus in agreement with our observation 
that MiDAS in Chk1-defective cells is SLX4/Mus81-independent 
(fig. S6, A and D). EdU events were frequently detected at sites where 
no gap/break was visible, but all gaps/breaks coincided with sites of 
newly synthesized DNA tracks (representative images in Fig. 4C). 
The frequency of EdU-localized gaps/breaks was steeply reduced after 
Eme1 depletion (Fig. 4D). We propose that Chk1 deficiency prompts 
Mus81-Eme1–dependent cleavage at sites of semiconservative DNA 
synthesis in early mitosis.
To further assess the notion that MiDAS is a prelude to Mus81-
Eme1–induced DNA damage, we abolished DNA synthesis in mitotic 
Chk1-deficient cells by depleting the Pol subunit PolD3 and the 
repair protein Rad52, two factors involved in MiDAS (Fig. 4, E and F) 
(24, 26). When MiDAS was prevented, Mus81-Eme1–dependent 
accumulation of DNA damage in mitotic cells (Fig. 4G), anaphase 
aberrations (Fig. 4H), and micronuclei (Fig. 4I) was not observed. 
Replication fork slowdown and pan-nuclear H2AX induced by Chk1 
loss remained unaltered upon PolD3 or Rad52 depletion, ruling out 
any link between these S phase phenotypes and the damage observed 
in mitosis (fig. S7, A and B). In summary, Chk1 depletion induces 
PolD3- and Rad52-dependent MiDAS, whose intermediates are 
cleaved by Mus81-Eme1, ultimately causing CIN.
Nucleotide deficiency during MiDAS leads to CIN in  
Chk1-deficient cells
MiDAS provides a mechanism to completing DNA duplication 
beyond the S phase and hence safeguards chromosomal stability 
(21, 25, 26). In apparent contrast, our data show that MiDAS 
jeopardizes chromosome stability in a Chk1-deficient background. 
In cells deficient in the DDR components Chk1 and WEE1, the 
availability of nucleotides is restricted (8, 9, 38, 41, 42). In WEE1- 
inhibited, but not in Chk1-inhibited, cells, nucleotide scarcity 
triggers replication catastrophe and chromosome pulverization 
(8, 9, 37, 38). How nucleotide scarcity affects DNA duplication in a 
Chk1- deficient background remains unknown. We reasoned that if 
the nucleotide pool shortens, MiDAS might become suboptimal, 
generating replication intermediates that are prone to cleavage 
by Mus81-Eme1.
In agreement with our hypothesis, the percentage of Chk1-deficient 
cells showing MiDAS increased upon supplementation with nucleo-
sides (Fig. 5A). These results suggest that, in mitotic Chk1-deficient 
cells, DNA is synthesized in a scenario of limited nucleotides, raising 
the intriguing possibility that such “limited” MiDAS leads to CIN. 
Nucleoside supplementation precluded the accumulation of mitotic 
H2AX foci (Fig. 5B), anaphase aberrations (Fig. 5C), and micronuclei 
(Fig. 5D). Thus, if supplemented with nucleosides, MiDAS in Chk1- 
depleted cells resembles MiDAS in APH-treated cells in terms of its 
ability to prevent chromosome mis-segregation, but not in terms of 
the molecular event that initiates MiDAS—MiDAS in Chk1-depleted 
cells remains independent of Mus81, even if extra nucleosides are 
supplied (fig. S8A). We propose that, instead of fostering a mecha-
nistic switch to a pathological type of MiDAS, nucleotide scarcity 
blocks the progression of replication forks in mitotic Chk1-deficient 
cells, thereby provoking Mus81-Eme1–dependent DSBs, which, in 
turn, generate CIN.
To strengthen the link between nucleotide starvation during 
MiDAS and CIN, we mimicked Chk1 depletion by combining APH 
and hydroxyurea (HU), which inhibits nucleotide biosynthesis. In a 
context of limited nucleotides (HU), APH-induced MiDAS was no 
Fig. 5. Nucleotide deficiency during MiDAS leads to CIN in Chk1-deficient cells. 
(A) Percentage of mitotic U2OS cells with EdU spots (mean ± SD). Nucleosides (Ns) 
were added 24 hours before fixation. About 120 metaphases per sample were 
analyzed in three independent experiments. (B) Percentage of mitotic U2OS cells 
with >10 H2AX foci (mean ± SD). Cells were treated as in (A). About 100 metaphases 
per sample were analyzed in three independent experiments. (C) Percentage of 
U2OS anaphase cells with aberrations (mean ± SD). Cells were treated as in (A). 
About 100 anaphases per sample were analyzed in two independent experiments. 
The total percentage of aberrant anaphases (bridges plus lagging chromosomes) 
was used to calculate the statistics. (D) Percentage of binucleated U2OS cells with 
micronuclei (mean ± SD). Cells were treated as in (A). About 400 binucleated cells 
per sample were analyzed in two independent experiments. (E) Model in which 
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longer dependent on Mus81 (fig. S8B) and correlated with Mus81- 
induced chromosome segregation defects (fig. S8C). Thus, although 
MiDAS is generally regarded as a process that safeguards genomic 
stability, if incomplete, MiDAS may propel genomic instability 
(Fig. 5E).
Nucleotide deficiency during MiDAS leads to DNA  
under-replication in Chk1-deficient cells
Our data indicate that MiDAS is limited by low nucleotide availability 
in Chk1-deficient cells. Given the originality of this concept, we 
sought to explore it further. We determined the frequency of UFBs 
in anaphase and 53BP1-nuclear bodies (53BP1-NBs) in G1. UFBs 
and 53BP1-NBs reveal UR-DNA that escapes MiDAS and persists 
until anaphase and the next G1, respectively (16, 29, 43–46). In 
agreement with our data in Fig. 4A, Chk1 depletion induced UFBs 
and 53BP1-NBs, and the induction of both was prevented by sup-
plementation with nucleosides (fig. S9, A and B). We conclude that 
the delivery of extra DNA precursors counteracts UR-DNA, probably 
by facilitating MiDAS.
We next depleted Rad52 to evaluate the effect of impeding MiDAS 
on the accumulation of UR-DNA. Rad52 depletion and nucleoside 
supplementation similarly attenuate chromosome segregation de-
fects in Chk1-deficient cells (Figs. 4, H and I, and 5, C and D). However, 
because Rad52 depletion impedes, rather than exacerbates, MiDAS, 
we did not expect that it resolved UR-DNA, like extra DNA precursor 
supply did (fig. S9, A and B). Rad52 depletion did not prevent the 
accumulation of 53BP1-NBs and even augmented the frequency of 
UFBs in Chk1-depleted cells (fig. S9, A and B). Together, our results 
indicate that although MiDAS is required, it is insufficient to prevent 
the inheritance of DNA lesions by daughter cells. An adequate nucleo-
tide supply is also needed, not to initiate MiDAS but to guarantee its 
completion and thereby avoid the aberrant activity of Mus81-Eme1.
CIN arising from nucleotide shortage during mitosis does 
not compromise survival of Chk1-deficient cells
We have described a molecular pathway leading to CIN in Chk1- 
depleted cells. Our data also show a dissection between chromosome 
mis-segregation and replication catastrophe. Replication catastrophe, 
which is characterized by pan-nuclear accumulation of H2AX and 
single-stranded DNA, leads to cell death in S phase (7–9, 11, 30, 38, 41). 
So, we reasoned that chromosome mis-segregation might not precede 
cell death in Chk1-deficient cells. To directly test this hypothesis, 
we evaluated the impact of reverting the chromosome segregation 
defects stemming from the aberrant processing of late replication 
intermediates on cell death. Preventing the accumulation of micro-
nuclei and anaphase aberrations by Rad52 depletion or exogenous 
nucleoside supply did not improve the survival of Chk1-deficient 
cells (Fig. 6A). Moreover, depletion of CDC45, which does not prevent 
chromosome mis-segregation, was sufficient to totally revert cell death 
upon Chk1 loss (Fig. 6B). In this regard, chromosome segregation 
errors correlate with the accumulation of H2AX foci in mitosis, 
whereas cell death correlates with the accumulation of pan-nuclear 
H2AX in S phase (Fig. 6B). These results demonstrate that chromo-
some mis-segregation is not the cause of cell death in Chk1-deficient cells.
DISCUSSION
This report uncovers a mechanism by which aberrant processing of 
DNA synthesis intermediates in mitosis causes CIN. Rather than 
culminating in cell death, this mechanism results in the inheritance 
of damaged DNA by daughter cells. Another key finding of this 
study is that MiDAS does not necessarily occur as a consequence of 
fork elongation or origin usage defects. Moreover, our work pre-
dicts that nucleotide availability determines the fate of late replica-
tion intermediates.
Chk1 loss leads to CIN
Despite our vast understanding of how Chk1 loss affects the S phase, 
few studies have addressed how Chk1 deficiency translates into 
genomic instability. This study confirms previous reports showing 
that Chk1 inactivation induces chromatin bridges and laggards (13, 15); 
it also shows that Chk1 deficiency triggers micronuclei accumulation. 
Micronuclei and anaphase aberrations are mechanistically related 
(17, 47–49), and this is supported by our data, as we observed a tight 
correlation between these two variables. Checkpoint defects precip-
itate chromosome mis-segregation as the result of S phase deregula-
tion or spindle assembly checkpoint failure (50). In Chk1-depleted 
cells, the fact that UR-DNA precedes chromosome mis-segregation 
favors S phase deregulation. However, the similarity in terms of 
chromosome segregation between siChk1 and siChk1-siCDC45 sam-
ples downplays the contribution of acute replication stress to CIN, 
although we cannot exclude the contribution of mild replication 
stress (minimal changes in fork speed or origin usage that escape 
detection by the established hallmark assays to monitor them).
Another key S phase parameter that could determine the success 
of chromosome segregation is timing of mitotic entry. That is, Chk1 
deficiency might induce anaphase aberrations and micronuclei by 
exiting the S phase with levels of UR-DNA that cannot be dealt with 
in mitosis. Chk1-deficient cells show premature mitotic onset as a 
result of untimely activation of the mitotic master regulators CDK1 
(cyclin-dependent kinase 1) and PLK1 (Polo-like kinase 1) (15, 51, 52). 
This is reminiscent of the faster progression through S phase ob-
served after inhibition of the DDR proteins ATR and WEE1 (20, 38). 
We speculate that Chk1-depleted cells reach mitosis with UR-DNA 
because of untimely mitotic entry.
MiDAS is the source of CIN upon Chk1 loss
Our work points to incomplete DNA synthesis in mitosis as a source 
of CIN (Fig. 6C). Moreover, we identified Mus81-Eme1 as a molecular 
trigger of CIN. Mus81-Eme1 is known to contribute to UR-DNA 
resolution and genome maintenance upon low-APH treatment by 
participating in the initiation of MiDAS (18, 19, 26). In Chk1-depleted 
cells, Mus81-Eme1 not only is dispensable for MiDAS initiation but 
also aberrantly processes UR-DNA undergoing MiDAS. This unfore-
seen activity of Mus81-Eme1 leads to the accumulation of mitotic 
DSBs and the ensuing CIN. At the molecular level, the requirement 
of a Mus81-dependent initial break might be the sole distinction 
between the MiDAS described previously and herein. Earlier studies 
postulated that APH-induced MiDAS is conservative (24, 26), con-
sistent with MiDAS being a BIR-like event (25); in agreement with 
a recent study (53), we show that both siChk1-induced MiDAS and 
APH-induced MiDAS are semiconservative. Thus, despite its re-
quirement for Rad52 and PolD3, two known molecular effectors of 
BIR, MiDAS is probably not a conservative BIR-like process.
To our knowledge, our work is the first one to identify Mus81-
Eme1–dependent cleavage of MiDAS intermediates as a source of 
CIN. Mus81-Eme1 normally initiates the repair of stalled replica-
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anaphases (18, 19, 26, 39). Because homologous recombination (HR) 
might function suboptimally in Chk1-deficient cells (54), the cleavage 
products of Mus81-Eme1 might be processed by error-prone mech-
anisms or aberrant forms of HR, causing CIN. In checkpoint- 
deficient cells, Mus81-Eme2–dependent cleavage of stalled forks in 
S phase also fails to initiate repair and instead results in widespread 
DNA damage and cell death (7, 8, 38). This observation might ex-
plain why MiDAS, a salvage pathway that supposedly implies DNA 
replication of UR-DNA persisting until mitosis, culminates in CIN. 
However, toxic processing of UR-DNA undergoing MiDAS might 
not be necessarily circumscribed to Chk1-depleted cells. Every time 
the nucleotide supply shortens during mitosis, cells might exceed 
a threshold of repairable UR-DNA, even in HR-proficient scenarios. 
So, our work introduces a key concept: MiDAS might promote proper 
chromosome segregation only if DNA synthesis reaches completion 
within a single M phase.
Nucleotide deficiency in mitosis triggers CIN and persistence 
of UR-DNA
The ATR-Chk1 pathway adjusts the nucleotide pool via control of 
RRM2, a regulatory subunit of the ribonucleotide reductase, which 
catalyzes the rate-limiting step for deoxynucleoside triphosphate 
(dNTP) production (41). Chk1-inhibited cells show reduced dNTP 
levels (42), resulting in the slowdown of replication forks (8, 9). 
Notwithstanding this, we and others have been unable to detect an 
effect of such nucleotide deficiency on the DNA damage load in 
S phase (8, 9, 37). Unexpectedly, we show here that nucleotide 
shortage promotes a pathological form of MiDAS that fuels mitotic 
DSBs and CIN (Fig. 6C).
There is consensus that the delivery of extra DNA precursors 
alleviates DNA replication stress by promoting fork elongation. 
Thus, several studies have linked reduced fork speed to genomic 
instability and/or cell death based on experiments that normalize 
Fig. 6. CIN arising from nucleotide shortage during mitosis does not compromise survival of Chk1-deficient cells. (A) Sensitivity of U2OS cells to Chk1 depletion 
and CDC45 or Rad52 depletion or nucleoside supplementation. Cell number was determined 6 days after transfection. Data represent the mean (±SD) of three independent 
experiments. The right panel shows representative images of the data. Scale bar, 500 m. (B) Graph showing that chromosome mis-segregation and cell death are uncor-
related in Chk1-deficient cells. Chromosome mis-segregation correlates with the accumulation of H2AX foci in mitosis, whereas cell death correlates with the accumula-
tion of pan-nuclear H2AX in S phase. Data correspond to Figs. 1E, 4I, and 5D (micronuclei); Fig. 6A (cell death); Figs. 3B, 4G, and 5B (H2AX foci in mitosis); and Fig. 1B and 
fig. S7A (pan-nuclear H2AX). The data on pan-nuclear H2AX upon Ns addition shown here are not presented in any preceding figure. (C) Model in which Chk1 loss 
triggers chromosome segregation defects and cell death by independent pathways. During S phase, Chk1 deficiency prompts surplus origin firing, reduced and asym-
metric fork elongation, and Mus81-Eme2–dependent DSBs, culminating in cell death (a). Independently of these S phase events, Chk1-deficient cells enter mitosis with 
UR-DNA, whose duplication is completed in mitosis only if extra DNA precursors are supplied (b). Otherwise, most replication intermediates in mitosis are cleaved by 
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the nucleotide pools (33, 42, 49, 55–57). We propose that such ex-
periments should be interpreted with care, as our findings indicate 
that nucleotide pools control DNA replication beyond the S phase. 
In this regard, it is important to highlight that the size of the dNTP 
pool peaks in S phase, in part due to tight control of RRM2 gene 
expression (58). Thus, nucleotide scarcity in mitosis is a typical 
scenario representing a threat to any cell that exits the S phase with 
high levels of UR-DNA. We conclude that cell cycle fluctuations of 
dNTP pools have the potential to challenge DNA replication in 
M phase and thereby induce anaphase anomalies.
CIN arising from nucleotide shortage in mitosis is not 
the cause of cell death in Chk1-deficient cells
Our study suggests that nucleotide starvation in Chk1-depleted cells 
impedes the accurate handling of UR-DNA, boosting genomic in-
stability, manifested as anaphase aberrations, micronuclei, UFBs, 
and 53BP1-NBs. Distortion of dNTP pools, mitotic onset before 
completion of DNA duplication, and abnormal anaphases have been 
associated with cell death in cells lacking DDR proteins, either ATR, 
WEE1, or ETAA1 (20, 23, 55). Intriguingly, however, we found no 
such causal connection between genomic instability and cell death 
in Chk1-depleted cells (Fig. 6C). We consider two scenarios that 
might explain this observation. First, DNA lesions sequestered in 
53BP1-NBs could be repaired during the next S phase (29), enabling 
cell survival. However, our model posits that not all UR-DNA in 
Chk1-depleted cells reaches the progeny bound to 53BP1. Second, 
chromosome segregation defects upon Chk1 loss might not be severe 
enough to impair the offspring’s fitness. In this case, genomic insta-
bility might get amplified across generations and so would the ensuing 
risk of acquiring selective growth advantages. We favor this possi-
bility, as aberrant anaphases and micronuclei, which accumulate upon 
Chk1 inactivation, precede cellular transformation (17). Thus, our 
findings could be exploited therapeutically through selective miti-
gation of at least one source of genomic instability in Chk1-directed 
therapies. This could be achieved by avoiding mitotic onset with 
UR-DNA or enabling its resolution through enhanced MiDAS.
Our results collectively challenge the simplistic view that defects 
in origin usage and/or fork elongation, mitotic abnormalities, and 
genomic alterations succeed each other before cell death. Given the 
clinical interest in developing therapeutic strategies that curtail genomic 
instability without compromising the killing efficiency, our study 
provides an important proof of concept for DDR-directed therapies.
MATERIALS AND METHODS
Cell culture and chemicals
U2OS (American Type Culture Collection), HCT116 (a gift from 
B. Vogelstein, Johns Hopkins University, Baltimore), and PANC-1 
(a gift from T. Seufferlein, Department of Internal Medicine, Uni-
versity of Ulm) were grown in Dulbecco’s modified Eagle’s medium 
(Invitrogen) with 10% fetal bovine serum (Natocor). EmbryoMax 
Nucleosides (1:1000; Millipore), APH (0.2 M; Sigma-Aldrich), and 
HU (100 M; Sigma-Aldrich) were added 24 hours before fixation; 
Gö6976 (1 M; Calbiochem) was added 36 hours before fixation.
Small interfering RNAs
Transfections were performed using JetPRIME (Polyplus) accord-
ing to the manufacturer’s instructions. Except from survival assays, 
cells were harvested 48 or 72 hours (H2AX detection in mitotic 
cells and 53BP1 detection in G1 and micronuclei assays) after trans-
fection. siRNAs were purchased from Dharmacon or Eurofins Ge-
nomics: siLuc (100 nM), 5′-CGUACGCGGAAUACUUCGA-3′ (59); 
siChk1 (100 nM), 5′-GAAGCAGUCGCAGUGAAGA-3′ (59); siCDC45 
(10 nM in U2OS and PANC-1 and 5 nM in HCT116), 5′-GCAAG-
ACAAGATCACTCAA-3′ (9); siMus81 (100 nM), 5′-CAGCCCUG-
GUGGAUCGAUA-3′ (39); siEme1 (100 nM), 5′-GCUAAGCAGUG-
AAAGUGA-3′ (18); siEme1#2 (100 nM), 5′-GCUCAAAGGCUUACAUGUA-3′ 
(18); siEme2 (100 nM), 5′-GCGAGCCAGUGGCAAGAG-3′ (39); 
siEme2#2 (50 nM), 5′-UGGAGCCCGAGGAGUUUCU-3′ (39); 
siRAD52 (100 nM), 5′-GGAGUGACUCAAGAAUUA-3′ (24); siPOLD3 
(50 nM), 5′-GAUAGUGAAGAGGAGCUUA-3′ (60); siSLX4 
(100 nM), 5′-GGAGAAGGAAGCAGAGAAU-3′ (61).
Lentiviral production and infection
The lentivirus production and infection were conducted exactly as 
previously described (9, 62).
Micronuclei assay
Twenty-four hours after transfection, cells were replated at low 
density. Twenty-four hours after replating, cytochalasin B (4.5 g/ml; 
Sigma-Aldrich) was added to the media, and after 36 hours, cells 
were fixed with 2% paraformaldehyde (PFA)/sucrose for 20 min. 
DAPI (Sigma-Aldrich) staining served to visualize nuclei. About 
200 binucleated cells were measured per sample per experiment. 
Representative images were acquired with a Zeiss Axio Observer 3 
microscope.
Anaphase aberration assay
Asynchronous cells were fixed with 2% PFA/sucrose for 20 min. 
When required, cells were incubated with nucleosides, APH/DMSO 
(dimethyl sulfoxide), or HU 24 hours before harvesting. DAPI 
(Sigma-Aldrich) staining served to visualize anaphases. About 
50 anaphases were measured per sample per experiment. Z-stacks 
were acquired with a Zeiss LSM 880 confocal microscope. Maximum 
intensity projections were generated using the Black ZEN Imaging 
Software (Zeiss).
Neutral comet assay
Neutral comet assay was conducted exactly as previously described (9).
Immunostaining and microscopy
Cells were fixed with 2% PFA/sucrose, and immunodetection of 
H2AX (1:1000; Millipore, 05-636), FANCD2 (1:500; Novus, NB100-182), 
53BP1 (1:1500; Santa Cruz Biotechnology, sc-22760), and PICH 
(1:100; Abnova, H00054821-B01P) was conducted exactly as previ-
ously described (9, 62, 63). Detection of S phase cells by EdU incor-
poration was performed exactly as previously described (62). Images 
of cells in interphase were acquired with a Zeiss Axio Observer 3 
microscope. Images of mitotic cells were acquired with a Zeiss LSM 
880 confocal microscope. H2AX fluorescence intensity was quan-
tified with the CellProfiler software (www.cellprofiler.org).
EdU labeling and detection in mitotic cells
Asynchronous cells were pulsed for 45 min with 20 M EdU, which 
was detected with the Click-iT EdU Alexa Fluor 555 Imaging Kit 
(Life Technologies), following the manufacturer’s instructions. DAPI 
(Sigma-Aldrich) staining served to visualize metaphases. About 
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were acquired with a Zeiss LSM 880 confocal microscope. Maximum 
intensity projections were generated using the Black ZEN Imaging 
Software (Zeiss).
Metaphase spreads and chromosome breakage
Chromosome aberration assays were conducted as previously described 
(64). Briefly, after a 24-hour treatment with colcemid (0.1 g/ml; 
KaryoMAX, Invitrogen), mitotic cells were collected, pelleted, sus-
pended in 75 mM KCl, incubated at 37°C for 5 min, and fixed using 
methanol:acetic acid (3:1). Cells were then dropped onto slides and 
aged for 24 hours before staining with 6% (w/v) Giemsa (Merck) for 
2 min. Images of metaphase chromosomes were acquired using an 
automated CytoVision system (version 3.7, Applied Imaging). About 
50 metaphases were analyzed per sample per experiment, and obvious 
chromosomal gaps/breaks were quantified.
EdU labeling and detection in chromosomes
As previously described in (26), cells were synchronized in late G2 
by incubation with 10 M RO-3306 (Calbiochem) for 20 hours, 
washed three times with phosphate-buffered saline (PBS) for 5 min, 
and released into fresh medium containing 20 M EdU and colcemid 
(0.1 g/ml; KaryoMAX, Invitrogen) for 60 min. Metaphase spreads 
and EdU detection were prepared/performed as described above. 
Chromosomes were stained with DAPI (Sigma-Aldrich). Images 
were acquired with a Zeiss LSM 880 confocal microscope and 
processed with the Black ZEN Imaging Software (Zeiss). About 
200 EdU-positive events were analyzed per sample per experiment.
DNA fiber spreading
DNA fiber spreading was conducted exactly as previously described 
(9, 62, 63).
Flow cytometry
Flow cytometry analyses were performed exactly as previously described 
(64). Briefly, cells were fixed with ice-cold ethanol and resuspended in 
PBS containing ribonuclease I (100 mg/ml; Sigma-Aldrich) and 
propidium iodide (50 mg/ml; Sigma-Aldrich). Samples were sub-
jected to fluorescence-activated cell sorting (Calibur, Becton Dickinson), 
and data were analyzed using the Summit 4.3 software (DAKO Cyto-
mation). Ten thousand events were analyzed per sample per experiment.
Quantitative real-time PCR
Quantitative polymerase chain reaction (PCR) was conducted ex-
actly as previously described (9, 63). Primer sequences were as 
follows: GAPDH (glyceraldehyde-3-phosphate dehydrogenase), 
5′-AGCCTCCCGCTTCGCTCTCT-3′ (forward) and 5′-GAGCGAT-
GTGGCTCGGCTGG-3′ (reverse) (63); EME1, 5′-CTCATCCCTGAG-
GGCTAGAA-3′ (forward) and 5′-AGTTGAAAGAGTGGCGGGA-3′ 
(reverse); EME2, 5′-AGGTGGAAGAGGCCCTGGTA-3′ (forward) 
and 5′-CCCTGCTGTGCAGAAGGAGA-3′ (reverse) (65); POLD3, 
5′-ACCTCCTTCTGTCAAGAGCT-3′ (forward) and 5′-CAGGAT-
TCACTCTCGTAGACT-3′ (reverse); RAD52, 5′-ACAGCGTTTG-
CCACCAGAA-3′ (forward) and 5′-ATGAGATTCCCAGTTTCCTGT-3′ 
(reverse); SLX4, 5′-AGTCGTGCTGTGTCACCTA-3′ (forward) and 
5′-CCTGTAGTCCCAGCTATCT-3′ (reverse).
Western blot
Cells were lysed and harvested with Laemmli buffer, followed by 
8 min of incubation at 99°C. The chromatin fraction was obtained 
after a 5-min extraction with ice-cold CSK buffer [10 mM Pipes 
(pH 7.5), 100 mM NaCl, 300 mM sucrose, 1 mM EGTA, 3 mM 
MgCl2, and 2% Triton X-100]. The following antibodies were used: 
-Chk1 at 1:1000 (Santa Cruz Biotechnology, sc-8408), -H2AX at 
1:4000 (Millipore, 05-636), -phospho-KAP1 Ser824 at 1:4000 (Bethyl 
Laboratories, A300-767A), -Mus81 at 1:1000 (Santa Cruz Biotech-
nology, sc-53382), -CDC45 at 1:1000 (Santa Cruz Biotechnology, 
sc-20685), -KAP1 at 1:4000 (Bethyl Laboratories, A300-274A), - 
phospho-RPA Ser4/8 at 1:8000 (Bethyl Laboratories, A300-245A), 
-H2B (histone 2B) at 1:2000 (Santa Cruz Biotechnology, sc-515808), 
and -actin at 1:20,000 (Sigma-Aldrich, A2066). Incubations with 
secondary antibodies (Jackson ImmunoResearch) and enhanced 
chemiluminescence (ECL) detection (GE Healthcare) were performed 
according to the manufacturers’ instructions. Western blot images 
were acquired with ImageQuant LAS4000 (GE Healthcare), which 
allows the capture and the quantification of images within a 
linear range.
Cell survival assays
Twenty-four hours after transfection, 1000 cells per well were re-
plated in 96-well plates. Five days after replating, cells were fixed 
with 2% PFA/sucrose for 20 min. DAPI staining served to visualize 
nuclei. INCell 2200 and INCell Analyzer WorkStation were used to 
image and count nuclei, respectively (9).
Statistical analysis
GraphPad Prism 5 was used for statistical analyses. Frequency dis-
tributions were analyzed with one-way analysis of variance (ANOVA) 
(followed by a Bonferroni posttest), and data shown as the mean 
(±SD) of independent experiments were analyzed with repeated- 
measures ANOVA (followed by a Newman-Keuls posttest). In all 
graphs, different letters indicate groups that are significantly different. 
Thus, if two samples share the same letter, they are not significantly 
different, while if two samples do not share any letter, they are sig-
nificantly different. P < 0.001 or P < 0.01 was considered significant 
for frequency distribution or data shown as the mean of indepen-
dent experiments, respectively.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/50/eabc8257/DC1
View/request a protocol for this paper from Bio-protocol.
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